Skip to main content

Biopharma Startups

Updated November 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 915 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
915
Total Funding
$652.8M
Avg Funding
$26.1M
Global Reach
8
countries

Top Cities for Biopharma

Boston
Oakland
Leuven
Montgomery
San Diego
Lyon

Recently Funded Companies

Export
Boston, United States

NeuroNOS is a company focused on developing innovative treatments for Autism Spectrum Disorder (ASD) and other neurological conditions.

$2.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Oakland, United States

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

$70.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Leuven, Belgium

Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases

$83.9M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Montgomery, United States

Foment Bio is a clinical-stage biotechnology company developing non-viral, off-the-shelf, gene based products.

$543K raised
Mar 2025

Founder Contacts

41,000+ verified contacts

San Diego, United States

Modulo Bio is a biotech company that offers a platform for reprogramming neurocells to improve immunity.

$4.8M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Boston, United States

Ampersand Biomedicines is a multi-product platform that develops programmable medicines that target disease sites precisely.

$65.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Lyon, France

Allogenica develops allogenic CAR-T cells using donor stem cells for cancer treatment.

$2.7M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

California City, United States

Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.

$4.5M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Arbor Biotechnologies is a biotechnology company specializing in next-generation gene editing therapeutics to treat genetic diseases.

$73.9M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Emeryville, United States

Topaz Biosciences develops biological solutions leveraging microbial diversity for research and skin health.

$1.4M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Bothell, United States

Curevo is a clinical-stage biotechnology company developing next-generation, non-mRNA vaccines for infectious diseases.

$110.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Irvine, United States

Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.

$125.0M raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Berkeley, United States

Prellis employs holographic tissue printing technology with fully human antibody discovery, in vitro human disease and ADME/Tox models.

Mar 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

MultiplAI Health is a leveraging advances in genomics and artificial intelligence to develop universal remote screening.

$295K raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Menlo Park, United States

Expanded Access software for biopharmaceuticals

Mar 2025

Founder Contacts

41,000+ verified contacts

London, United Kingdom

Lifelancer is a global platform for talent hiring in Life Sciences, Pharma, Healthtech & IT

$236K raised
Mar 2025

Founder Contacts

41,000+ verified contacts

Exton, United States

Castle Creek Biosciences is focused on developing commercializing novel, personalized gene therapies for rare skin disorders.

$75.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

New York, United States

Ambient Multimodal AI for Mental Health

Feb 2025

Founder Contacts

41,000+ verified contacts

Albuquerque, United States

YEEO Eco-Safe develops insect control products using plant-derived essential oils combined with yeast encapsulation technology.

$1.1M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Schlieren, Switzerland

LimmaTech Biologics is a biotech company that develops vaccines to prevent microbial infections and address antimicrobial resistance.

$6.5M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Garching Bei Múnchen, Germany

Invitris is a biotech company that develops protein-based drugs.

Feb 2025

Founder Contacts

41,000+ verified contacts

Tarpon Springs, United States

A clinical-stage biopharmaceutical company identifying and developing therapeutics for the treatment of fungal and bacterial infections.

$3.3M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Madrid, Spain

Amadix is a biotechnology company focused on the development and commercialization of diagnostic tools for personalized oncology treatment.

$15.5M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Salt Lake City, United States

Rebel Medicine develops medicine for opioid-free pain management.

$6.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Genova, Italy

GI develops super-resolution optical microscopes, empowering researchers to explore the microscopic world with unprecedented detail.

$1.0M raised
Feb 2025

Founder Contacts

41,000+ verified contacts

Showing 401 to 425 of 915 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 915 biopharma companies tracked in the VCBacked database.

Average Funding
$26.1M
Total Funding Tracked
$652.8M
Countries Represented
8

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.Boston
2 companies$67.0M
2.London
2 companies$530K
3.Oakland
1 companies$70.0M
4.Leuven
1 companies$83.9M
5.Montgomery
1 companies$543K

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked